A Study of Ferric Citrate to Improve Inflammation and Lipid Levels

NCT02661295 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Stopped 38 enrolled, 19 completed the study when loss of funding occurred

Conditions

End Stage Renal Disease
Hyperphosphatemia
Chronic Inflammation

Interventions

DRUG: Ferric Citrate

Sponsor

Winthrop University Hospital

Collaborators

[object Object]